We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+9.84%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$15.7B
AUM Growth
+$958M
Cap. Flow
-$459M
Cap. Flow %
-2.93%
Top 10 Hldgs %
22.96%
Holding
925
New
41
Increased
262
Reduced
364
Closed
130

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$97.5M
2
PYPL icon
PayPal
PYPL
+$66.8M
3
HOLX
Hologic
HOLX
+$44.4M
4
BNTX icon
BioNTech
BNTX
+$35M
5
TMO icon
Thermo Fisher Scientific
TMO
+$34.3M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$80.5M
2
XLRN
Acceleron Pharma
XLRN
+$79.5M
3
AAPL icon
Apple
AAPL
+$55.8M
4
ONC
BeOne Medicines Ltd
ONC
+$44.9M
5
VZ icon
Verizon
VZ
+$37.9M

Sector Composition

Rank Sector Weight
1 Healthcare 31.29%
2 Technology 26.69%
3 Financials 8.86%
4 Communication Services 7.82%
5 Consumer Discretionary 7.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TAK icon
826
Takeda Pharmaceutical
TAK
$56B
– –
-76
Closed -$1K
TEF
827
DELISTED
Telefonica
TEF
– –
-387
Closed -$2K
TEL icon
828
TE Connectivity
TEL
$62.1B
– –
-18
Closed -$2K
TM icon
829
Toyota
TM
$221B
– –
-35
Closed -$6K
TPIC
830
DELISTED
TPI Composites
TPIC
– –
-33,783
Closed -$1.14M
TRGP icon
831
Targa Resources
TRGP
$56.2B
– –
-4,167
Closed -$205K
TT icon
832
Trane Technologies
TT
$104B
– –
-17
Closed -$3K
TTE icon
833
TotalEnergies
TTE
$187B
– –
-20
Closed -$1K
UAL icon
834
United Airlines
UAL
$40.2B
– –
-4,822
Closed -$229K
UBER icon
835
Uber
UBER
$144B
– –
-33,657
Closed -$1.51M
VOD icon
836
Vodafone
VOD
$37.7B
– –
-71
Closed -$1K
VOYA icon
837
Voya Financial
VOYA
$9.07B
– –
-4,405
Closed -$270K
VTEX icon
838
VTEX
VTEX
$745M
– –
-267,000
Closed -$5.49M
VV icon
839
Vanguard Large-Cap ETF
VV
$52B
– –
-1,180
Closed -$237K
WFG icon
840
West Fraser Timber
WFG
$5.28B
– –
-3,505
Closed -$295K
WK icon
841
Workiva
WK
$3.28B
– –
-10,000
Closed -$1.41M
XPEV icon
842
XPeng
XPEV
$12.2B
– –
-9,375
Closed -$333K
EVA
843
DELISTED
Enviva Inc.
EVA
– –
-70,001
Closed -$3.79M
LSXMK
844
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
– –
-18,406
Closed -$677K
NGM
845
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
– –
-564,059
Closed -$11.9M
IMGN
846
DELISTED
Immunogen Inc
IMGN
– –
-2,562,935
Closed -$14.5M
AGRX
847
DELISTED
Agile Therapeutics
AGRX
– –
-15
Closed -$28K
CLR
848
DELISTED
CONTINENTAL RESOURCES INC.
CLR
– –
-4,659
Closed -$215K
PHAS
849
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
– –
-1,081,258
Closed -$3.36M
AVLR
850
DELISTED
Avalara, Inc.
AVLR
– –
-4,510
Closed -$788K
32 33
34
35 36

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q4 2021 Portfolio in Review

As of Q4 2021, Candriam SCA held 925 positions worth $15.7B, up 6.5% from $14.7B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Candriam SCA's Q4 2021 filing shows 41 new, 262 increased, 364 reduced and 130 closed positions. Its largest new stake was Couchbase: 858,038 shares worth $21.4M. The largest sale was Merck, an estimated $80.5M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 32% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q4 2021 buy was Couchbase: 858,038 shares worth $21.4M.
  • Candriam SCA added most to Eli Lilly in Q4 2021, an estimated $97.5M increase.
  • Candriam SCA's biggest Q4 2021 reduction was Merck, cutting an estimated $80.5M.
  • Candriam SCA fully exited Acceleron Pharma in Q4 2021, selling an estimated $79.5M.
  • Candriam SCA's ten largest holdings make up 23% of its $15.7B portfolio in Q4 2021.
  • Candriam SCA opened 41 new positions and closed 130 in Q4 2021.
  • Candriam SCA's portfolio value rose 6.5% quarter-over-quarter to $15.7B.

Based on Candriam SCA's 13F filing for Q4 2021, filed 10 Feb 2022.